Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

NEW
STU:4E2 (USA)  
€ 3.88 -0.040 (-1.02%) Aug 24
At Loss
P/B:
2.37
Market Cap:
€ 418.23M ($ 488.37M)
Enterprise V:
€ 231.84M ($ 270.72M)
Volume:
0
Avg Vol (2M):
3.67K
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

AAPL Stock Intrinsic Values - Apple Inc